Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Orgenics is a medical diagnostics company specializing in the development and manufacture of rapid, point-of-care diagnostic tests. Founded in Israel, the company is best known for its proprietary ImmunoComb technology, which allows for the simultaneous detection of multiple antibodies or antigens in a single sample. Their product portfolio primarily focuses on infectious diseases, including HIV, Hepatitis, and various respiratory and tropical diseases. Orgenics was acquired by Inverness Medical Innovations (now part of Abbott) and continues to provide diagnostic solutions globally, particularly in resource-limited settings. The company's products are valued for their robustness and ability to provide laboratory-quality results without complex infrastructure.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Orgenics.